Advances in the Treatment of Myelodysplastic Syndromes: Expert Guidance for Clinical Practice in 2020

Get expert insights on the optimal multidisciplinary care of patients with MDS in 2020 with this series of concise interactive virtual presentations, commentaries, and a new mobile-friendly format for getting expert recommendations individualized to your specific patient scenario with CCO’s Interactive Decision Support Tool.
Guillermo Garcia-Manero, MD

ClinicalThought

How will you incorporate luspatercept into your clinical practice for your patients with anemia associated with MDS? Learn from an expert in this commentary.

Guillermo Garcia-Manero, MD Released: October 14, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Bristol-Myers Squibb

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue